Harbor Capital Advisors, Inc. Sarepta Therapeutics, Inc. Transaction History
Harbor Capital Advisors, Inc.
- $2.3 Billion
- Q3 2024
A detailed history of Harbor Capital Advisors, Inc. transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Harbor Capital Advisors, Inc. holds 1,279 shares of SRPT stock, worth $166,909. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,279
Previous 1,273
0.47%
Holding current value
$166,909
Previous $201,000
20.4%
% of portfolio
0.01%
Previous 0.02%
Shares
8 transactions
Others Institutions Holding SRPT
# of Institutions
530Shares Held
84.5MCall Options Held
2.06MPut Options Held
1.52M-
Black Rock Inc. New York, NY10.3MShares$1.35 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.97MShares$1.17 Billion0.02% of portfolio
-
Capital International Investors Los Angeles, CA6.26MShares$817 Million0.16% of portfolio
-
Janus Henderson Group PLC London, X04.36MShares$569 Million0.29% of portfolio
-
State Street Corp Boston, MA4.27MShares$557 Million0.02% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $11.4B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...